C91.02
C91.02: Acute lymphoblastic leukemia, in relapse
Billable / specific codeICD-10-CM
C91.02 is a billable, specific ICD-10-CM code for acute lymphoblastic leukemia, in relapse. It is valid for submission on a claim.
Check C91.02 with the rest of the claim: free scrubberOther codes that can never be billed with C91.02
Their own Excludes1 notes name this code, so the conflict is not listed above.
- D72.825Bandemia
Risk adjustment
C91.02 risk-adjusts. Under the CMS-HCC V28 model it maps to these categories:
- HCC 18 Cancer Metastatic to Bone, Other and Unspecified Metastatic Cancer; Acute Leukemia Except Myeloid2.341 RAF
- HCC 18 Cancer Metastatic to Bone, Other and Unspecified Metastatic Cancer; Acute Leukemia Except Myeloid2.341 RAF
Coefficient shown for the Community Non-dual Aged segment. A higher HCC in the same hierarchy will suppress this one, so capturing it does not always add score. Look up the whole chart to see which of its HCCs the hierarchy would zero.
Medicare coverage
C91.02 is named in 53 Medicare coverage policies: 53 listing it as supporting medical necessity. Which one applies depends on your Medicare contractor.
- A52479Oral Anticancer Drugs - Policy Article
- A52480Oral Antiemetic Drugs (Replacement for Intravenous Antiemetics) - Policy Article
- A52507External Infusion Pumps - Policy Article
- A52986Billing and Coding: Biomarkers for Oncology
Code history
Unchanged in every release from FY2024 to FY2027.